Private RSV Vaccine in London
RSV is a common winter virus that puts thousands of older adults, and people with heart, lung, kidney or immune conditions, in hospital every year. The NHS vaccinates only some of the adults the vaccine is licensed for. If you're outside the NHS programme, you can be protected privately at our Hampstead clinic with Abrysvo, the same RSV vaccine the NHS uses. One appointment. £240, all-inclusive.
Updated for the NHS eligibility change of 1 September 2026. See who the NHS now covers, and who it doesn't →
Senior specialist pharmacist · 35 South End Road, Hampstead NW3 · Live online booking, no phone calls
Not eligible on the NHS? You can still protect yourself.
From 1 September 2026 the NHS offers a free RSV vaccine to adults aged 75 and over, care-home residents, pregnant women from 28 weeks, and adults aged 65 to 74 with a weakened immune system or a serious long-term lung condition. Who gets it free is decided by what is cost-effective for the NHS as a whole, not by whether you personally would benefit. That leaves most people aged 60 to 74, and every at-risk adult under 65, without NHS cover. All of them can be vaccinated privately.
You can be vaccinated privately with us if you are:
- Aged 60 to 74 and not in an NHS risk group. The vaccine is licensed for everyone aged 60 and over, but below 75 the NHS funds it only for care-home residents and for two specific risk groups from age 65.
- Aged 60 to 64 with any long-term condition, including a weakened immune system or lung disease. The NHS risk-group offer starts at 65.
- Aged 65 to 74 with a condition that isn't on the NHS list, such as heart disease, diabetes, kidney or liver disease, a neurological condition or well-controlled asthma.
- Aged 18 to 59 with a condition that raises your RSV risk: a weakened immune system (blood cancer, chemotherapy, a transplant, biologic medicines, HIV or long-term high-dose steroids), chronic lung, heart, kidney or liver disease, diabetes or a neurological condition.
- Eligible for the NHS vaccine but unable to get an NHS appointment before the RSV season, or before your baby is due.
- Vaccinated two or more RSV seasons ago and still at high risk. No booster is officially recommended yet, but we can review it with you individually (see below).
Under 60 and struggling to find anyone who will vaccinate you?
Not every clinic offers the RSV vaccine below age 60. Abrysvo is licensed from 18 for adults at increased risk, and we vaccinate this group routinely, including patients sent to us by their haematologist, oncologist, transplant or respiratory team. Patients travel to us from outside London for this. If you have a clinic letter mentioning your condition or treatment, bring it; it isn't required, but it helps us record why you're at increased risk.Who can have the RSV vaccine? The NHS gap at a glance
Abrysvo is licensed for every adult aged 60 and over, and for adults aged 18 to 59 at increased risk. From 1 September 2026 the NHS funds it for adults 75 and over, care-home residents, pregnant women, and 65 to 74-year-olds in two risk groups. Everyone else within the licence can have it privately with us.
| Your age | No long-term condition | Another long-term condition* | Weakened immune system or listed lung condition† |
|---|---|---|---|
| 18–59 | Not licensedNo RSV vaccine is licensed for healthy under-60s |
Private with usLicensed from 18 for adults at increased risk |
Private with usNot NHS-funded below 65Risk matches 75+ |
| 60–64 | Private with usLicensed for all adults aged 60 and over |
Private with usLicensed for all adults aged 60 and over |
Private with usNHS risk-group offer starts at 65Risk matches 75+ |
| 65–74 | Private with usNot in an NHS risk group |
Private with usCondition not on the NHS list |
Free on the NHSAsk your GP surgeryNew: Sept 2026 |
| 75+ | Free on the NHSEveryone aged 75 and over, whatever their health, with no upper age limit. Ask your GP surgery. |
||
* Conditions that raise your RSV risk but aren't on the NHS list: heart disease (high blood pressure alone doesn't count), diabetes, kidney or liver disease, neurological conditions, well-controlled asthma, blood disorders, and thyroid or other metabolic conditions.
† The two NHS risk groups (Green Book, Table 1): a weakened immune system from disease or treatment (for example chemotherapy or radiotherapy, leukaemia, lymphoma or myeloma, an organ, bone-marrow or stem-cell transplant, biologic medicines, long-term high-dose steroids, or HIV) and chronic lung disease (COPD, bronchiectasis, cystic fibrosis, interstitial lung fibrosis, pneumoconiosis, bronchopulmonary dysplasia, or asthma that has needed steroid tablets or a hospital admission in the last two years).
The two "Risk matches 75+" cells are the ones the NHS's own data say matter most. UKHSA found that adults under 65 with a weakened immune system or chronic lung disease are admitted to hospital with RSV at rates matching or exceeding the over-75s, but extending NHS funding below 65 was judged unlikely to be cost-effective. That is a budget decision, not a judgement on your risk. Your pharmacist will confirm suitability at your appointment.
Understand your RSV risk
What is RSV?
Respiratory syncytial virus (RSV) is a common, very contagious virus that infects the nose, throat and lungs.
In healthy adults it usually feels like a heavy cold. But in older adults and people with underlying conditions, RSV can move into the lower airways and cause serious illness such as pneumonia, and can trigger flare-ups of COPD, asthma and heart failure. Previous infection gives only partial immunity, so you can catch it again and again. In the UK it circulates mainly from October to February, with most infections packed into about six weeks around the mid-winter peak.
Who is at higher risk?
Risk rises with age and with long-term health conditions, and the two together multiply the danger.
- Aged 60 or over (especially 75+)
- A weakened immune system: blood cancer, chemotherapy, a transplant, biologic medicines, HIV or long-term high-dose steroids
- Chronic lung disease: COPD, bronchiectasis, interstitial lung disease, cystic fibrosis, poorly controlled asthma
- Chronic heart disease, including heart failure
- Diabetes, chronic kidney or liver disease, neurological conditions
- Living with frailty or in a care home
What could happen?
For higher-risk adults, RSV is not "just a cold": it's a recognised cause of hospital admission and, in the frailest, of death.
RSV can cause pneumonia, low oxygen levels needing hospital treatment, and dangerous flare-ups of existing heart and lung conditions. In the winter before the NHS programme began, an older adult admitted with RSV was as likely to die within 30 days as one admitted with flu. Vaccination is the most effective way to reduce that risk.
About the RSV vaccine we use
We vaccinate with Abrysvo (Pfizer), the same RSV vaccine the NHS uses for its older-adult and pregnancy programmes.
What it is
A protein-based (non-live) RSV vaccine given as a single injection into the upper arm. Licensed in the UK for adults aged 60 and over, adults aged 18 to 59 at increased risk of RSV lung disease, and pregnant women from 28 weeks.
How well it works
In the first season of the UK programme, vaccination cut the risk of being admitted to hospital with RSV by 82% in adults aged 75 to 79, rising to 87% for the most severe illness, in a UKHSA study across 14 English hospitals (Symes et al., Lancet Infectious Diseases, 2025). Protection was around 73% in people with a weakened immune system. In the licensing trial, protection against more severe RSV illness was 89% in the first season.
What to expect
A short appointment and a single jab. The most common side effects are tiredness, headache, a sore arm and aching muscles for a day or two. Serious reactions are very rare. In adults aged 60 and over, a small increased risk of Guillain-Barré syndrome (a rare nerve condition) has been seen in the weeks after RSV vaccination; the benefits clearly outweigh it. If you notice tingling, numbness, weakness or pins and needles in your hands, feet, arms or legs after vaccination, seek medical help promptly. Your pharmacist talks all of this through with you first.
How long does protection last, and will I need a booster?
One dose. No booster is currently recommended by the UK Green Book or by the vaccine's licence, because the right timing hasn't been established. Trials show strong protection through two RSV seasons; beyond that it is expected to fade gradually. If you had your dose two or more seasons ago and remain at high risk, we'll review it with you individually.
Sources: Abrysvo Summary of Product Characteristics (May 2026) and the UKHSA Green Book RSV chapter (June 2026).
What the evidence says about repeat doses
- The licence: "the need for revaccination has not been established".
- The Green Book: protection lasts at least two years and there are no current data to support revaccinating older adults. The NHS gives one dose only, and people vaccinated at 65 to 74 are not re-invited at 75.
- Early repeat doses don't help: a second Abrysvo dose one month after the first added nothing in adults with a weakened immune system, and in the manufacturer's early studies a second dose given two months or twelve months after the first produced no boost, or a smaller antibody rise than the first dose. With another RSV vaccine, a repeat dose 12 months on gave no extra protection in its trial.
- Third-season evidence is only now arriving. The first real-world look at a third season suggests protection is still present but lower, with a wide margin of error. It is not yet strong enough for anyone, us included, to recommend a booster on.
- The three-and-four-year question is being tested now. The manufacturer's main trial has a registered sub-study giving a placebo-controlled repeat dose at around three or four years after the first. Its results, expected from 2027, are the ones that will tell us whether and when a booster helps.
Our approach
- One dose, properly recorded. You and your GP receive a vaccination record with the date.
- A private dose now doesn't cost you an NHS dose later. Under the NHS programme rules, people vaccinated privately are still invited for their free dose when they become eligible (at 75, or at 65 with a qualifying condition). The NHS does ask for at least 24 months between a private dose and its own, so if you're within two years of becoming eligible, it's worth weighing the free dose against paying now.
- Two or more seasons on and still at high risk? Email us your vaccination date and condition. We'll tell you honestly whether a repeat dose is worth considering on the evidence at the time, so you don't book an appointment you don't need.
- We only re-vaccinate where our prescriber judges it clinically appropriate for you.
When to get vaccinated
RSV spreads mainly from October to February, so late summer to early autumn is the ideal time. It isn't a seasonal vaccine, though: one dose covers you for at least two seasons and it is available all year round. If winter has already started, don't wait.
An established private immunisation clinic, trusted since 2014
Your RSV vaccination is given by Mahyar Saremi, our senior specialist pharmacist (Superintendent Pharmacist & Independent Prescriber), at a long-established North London clinic rated 4.8/5 across 400+ Google reviews. A reliable, straightforward service from start to finish.
Your appointment includes
- A private suitability check with our senior specialist pharmacist
- The Abrysvo RSV vaccine
- Administration and a short observation period
- Aftercare advice and a vaccination record for you and your GP
Why patients choose us
- Senior specialist pharmacist: Mahyar Saremi, Superintendent Pharmacist & Independent Prescriber (GPhC 2069409)
- Established since 2014: a trusted, independent North London immunisation clinic
- We vaccinate at-risk adults from 18, not just the over-60s
- Convenient Hampstead location: 35 South End Road, NW3 2PY, opposite Hampstead Heath Rail Station
- Live online booking: instant confirmation, no phone calls, same-day slots often available
- Can be given with your COVID-19, shingles or pneumococcal vaccine; flu is normally given on a different day, with no minimum gap (your pharmacist will advise)
Book your RSV vaccination in 3 simple steps
Book online
Choose your appointment and pay a £25 deposit to reserve it.
Quick suitability check
Your pharmacist confirms the vaccine is right for you.
Get vaccinated
One injection plus aftercare advice, and you settle the balance at the pharmacy.
- Your deposit is not an extra charge. The £25 you pay at booking reserves your appointment and comes off the £240 in full when you visit.
- Change your mind? Cancel or reschedule with at least 48 hours' notice and we refund almost all of your deposit, less a £1 administrative fee for card processing.
- If the vaccine can't be given after your assessment, only a capped £25 consultation fee applies, not the full price.
- Late cancellation (under 48 hours) or a missed appointment: £25.
Secure booking by Semble · ISO 27001 & GDPR compliant
Covers your consultation with our specialist pharmacist, the Abrysvo vaccine, administration and aftercare, with your vaccination record sent to you and your GP. No hidden fees. The £25 deposit you pay at booking is deducted in full from this price. See the full price list for all our vaccines.
Book your appointment →Private RSV vaccine: frequently asked questions
Who can have the RSV vaccine privately?
Any adult within the vaccine's licence who isn't covered by the NHS: adults aged 60 to 74 outside the NHS risk groups, adults aged 60 to 64 with any long-term condition, adults aged 65 to 74 with a condition that isn't on the NHS list, and adults aged 18 to 59 with a condition that raises their RSV risk. Your pharmacist confirms you're suitable at the appointment.
What changed on 1 September 2026?
The NHS extended free RSV vaccination to adults aged 65 to 74 with a weakened immune system or a serious long-term lung condition (COPD, bronchiectasis, cystic fibrosis, interstitial lung fibrosis, pneumoconiosis, bronchopulmonary dysplasia, or asthma that has needed steroid tablets or a hospital stay in the last two years). If that's you, ask your GP surgery for the free vaccine. Adults under 65, and other conditions such as heart disease or diabetes, are still not covered.
I'm under 65 with blood cancer, on chemotherapy or on medicines that weaken my immune system. Can you vaccinate me?
Yes. Abrysvo is licensed from age 18 for adults at increased risk, which includes people with leukaemia, lymphoma or myeloma, people having chemotherapy or biologic treatment, transplant recipients and people on long-term high-dose steroids. The NHS doesn't fund it below 65, even though its own data show your hospital risk matches the over-75s. Your protection may be a little lower than in someone with a healthy immune system, but UK guidance is to vaccinate anyway. A clinic letter is helpful but not required.
I'm 62 with COPD. The NHS says I'm not eligible until 65. Can I have it now?
Yes. The vaccine is licensed for everyone aged 60 and over. The NHS risk-group offer only starts at 65, so at 60 to 64 you can be vaccinated privately. Having a private dose now doesn't stop you being offered a free NHS dose later; under the programme rules you would still be invited when you become eligible.
I'm 68 with heart disease or diabetes. Am I covered by the NHS?
Not at the moment. At 65 to 74 the NHS funds only two groups: a weakened immune system and the listed chronic lung conditions. Heart disease, diabetes, kidney and liver disease, well-controlled asthma and neurological conditions all raise your RSV risk but aren't yet covered, so you can have the vaccine privately with us. The JCVI is still reviewing these conditions.
I'm eligible for the NHS vaccine. Should I still pay?
No. If you're eligible, get it free from your GP surgery, or from your maternity service if you're pregnant. We only suggest a private dose if you can't get an NHS appointment in time, for example a pregnant woman close to her due date. This applies to a small number of people.
Is this the same vaccine as the NHS gives?
Yes. We use Abrysvo (Pfizer), the same RSV vaccine used in the NHS older-adult and pregnancy programmes.
How much does it cost? Are there any hidden fees?
£240, all-inclusive, covering the consultation, the vaccine, administration and aftercare. The £25 deposit you pay when booking comes off that total, so there is nothing else to pay. If you cancel or reschedule with at least 48 hours' notice we refund your deposit less a £1 administrative fee. Late cancellation or a missed appointment is charged at £25, and if your assessment means the vaccine can't be given, only a capped £25 consultation fee applies.
How effective is the RSV vaccine?
Very effective. In the first season of the UK programme it cut the risk of hospital admission with RSV by 82% in adults aged 75 to 79, and by 87% for the most severe illness, in a UKHSA study across 14 English hospitals. Across all four UK nations the figure was 75%. Protection was around 73% in people with a weakened immune system. In the licensing trial, protection against more severe RSV lung illness was 89% in the first season and about 78% in the second.
How long does protection last? Will I need a booster?
One dose is all that's currently recommended. Trials show strong protection through two RSV seasons, and it is expected to fade gradually after that. No booster is recommended yet by the Green Book or the vaccine's licence, because the right timing hasn't been established and early repeat doses haven't added protection in trials. If you're two or more seasons on and still at high risk, email us and we'll review it with you.
I had the RSV vaccine a few years ago. Can I have another?
Not routinely. No UK guidance currently recommends a booster, and the NHS gives one dose only. We consider a repeat dose only where our prescriber judges it clinically appropriate, for example a patient at high risk who is several seasons on. Email us your vaccination date and condition first and we'll tell you whether an appointment is worthwhile.
Will a private dose now stop me getting the free NHS dose later?
No. Under the NHS programme rules, people who have had an RSV vaccine privately are still invited for their free NHS dose when they become eligible, at 75 or at 65 with a qualifying condition. UKHSA guidance asks for a minimum of 24 months between a private dose of Abrysvo and the NHS dose, following a discussion of the benefits and risks, because protection is known to last at least that long. So if you're within two years of becoming NHS-eligible, tell us at your assessment and we'll talk through whether waiting for the free dose makes more sense for you.
Is the RSV vaccine safe? What are the side effects?
The most common side effects are tiredness, headache, a sore arm and muscle aches for a day or two. Serious reactions are very rare. In adults aged 60 and over, a small increased risk of Guillain-Barré syndrome (a rare nerve condition) has been seen in the six weeks after RSV vaccination: roughly 10 to 25 extra cases per million doses, against a background rate of about 20 per million per year in people aged 70 to 79. The Commission on Human Medicines has concluded the benefits of vaccination clearly outweigh this risk. Seek medical help promptly if you notice tingling, numbness, weakness or pins and needles in your hands, feet, arms or legs. Please read the Patient Information Leaflet; your pharmacist will discuss this and any other precautions with you.
Can I have it at the same time as my flu, COVID or shingles vaccine?
Shingles, COVID-19 and pneumococcal vaccines can be given at the same visit. Flu is different: national guidance is not to routinely give a flu vaccine on the same day as the RSV vaccine in older adults, because studies show a somewhat lower immune response to both when they are given together. That applies whichever flu vaccine you have, including the cell-based flu vaccine we give in the pharmacy. No minimum gap is required, so any other day works: many patients have their flu jab first and come back for RSV, or the other way round. If you need protection straight away, or a second visit isn't realistic for you, the two can be given together. In pregnancy, flu and COVID-19 vaccines can safely be given with RSV. Let us know which other vaccines you've had or are due.
When is the best time to get vaccinated?
RSV circulates mainly from October to February, peaking in late November and December, so late summer to early autumn is ideal. It isn't a seasonal vaccine, though: one dose covers at least two seasons and it can be given all year round. If winter has already started, don't wait.
Do I need a referral or a prescription?
No. Our pharmacist assesses your suitability at the appointment, with no GP referral or prescription needed. If you're under 60, a clinic letter mentioning your condition or treatment is helpful but not essential. Consultants are welcome to refer patients; see the clinician section below.
Where are you and how do I get there?
We're at 35 South End Road, Hampstead, London NW3 2PY, directly opposite Hampstead Heath Rail Station (Mildmay line). Belsize Park (Northern line) is about a 10 to 12 minute walk, with direct trains from Euston and King's Cross St Pancras if you're travelling from outside London. Bus routes 24, 46, 168 and C11 serve South End Green. On-street parking nearby is limited and pay-and-display, so public transport is usually easiest.
Can you vaccinate me at home?
Yes. We offer home vaccinations across our local area, with a minimum call-out fee of £100 plus the cost of the vaccine. This can be ideal if you're housebound or would prefer not to travel. Email your postcode to info@hhpharmacy.co.uk for a quote.
Referring patients who fall outside the NHS RSV programme
The licence for RSV vaccination is wider than NHS funding. We vaccinate the adults in that gap with the same vaccine as the NHS programme, assessed and given by Mahyar Saremi, Superintendent Pharmacist and Independent Prescriber.
Why it matters below 75
UKHSA's linked-data analysis for the JCVI (March 2026) found RSV admission rates in adults with immunosuppression or chronic respiratory disease (excluding well-controlled asthma) at or above the over-75 benchmark in every adult age band examined, including 50 to 64 and 18 to 49. The NHS extended funding to 65 to 74 in those two groups from 1 September 2026. Extension below 65 was judged unlikely to be cost-effective, because most of the modelled benefit is averted mortality, which concentrates in older adults. That is a population-level funding decision. The individual risk for a patient in their fifties on chemotherapy is unchanged by it.
Effectiveness
Single dose. No revaccination is currently recommended. NHS eligibility is retained after a private dose, subject to UKHSA's 24-month minimum interval.
Who we can vaccinate (within licence)
- 18 to 64 with immunosuppression: haematological malignancy, chemotherapy or radical radiotherapy, solid organ or stem-cell transplant, biologics, systemic steroids at 20 mg prednisolone-equivalent or more daily for over a month, HIV.
- 18 to 64 with chronic respiratory disease: COPD, bronchiectasis, ILD, cystic fibrosis, poorly controlled asthma.
- 18 to 74 with other conditions that raise RSV LRTD risk: chronic cardiovascular disease (excluding isolated hypertension), diabetes, CKD, chronic liver disease, neurological disease, well-controlled asthma.
- Any adult aged 60 to 74 outside the NHS risk groups.
How to refer
No referral letter is needed. Direct your patient to hhpharmacy.co.uk/private-rsv-vaccine-london to self-book. A clinic letter or note stating the indication helps for the 18 to 59 cohort and is filed with the record.
- We assess suitability, vaccinate and observe. A full record goes to the patient and their GP, and to you on request (info@hhpharmacy.co.uk).
- Same-day slots are often available. Patients travel to us from outside London; we are directly opposite Hampstead Heath Rail Station.
References: SmPC, revision 05/2026 (emc) · UKHSA Green Book, RSV chapter 27a, 3 June 2026 · JCVI advice on adults at higher risk of RSV, 18 March 2026 · NHSE/UKHSA expansion letter, 1 July 2026 · UKHSA practitioner guidance, older adults, August 2026 · Symes R et al. (HARISS), Lancet Infect Dis 2025 (doi) · Walsh EE et al. (RENOIR), Clin Infect Dis 2025.
Protect yourself this RSV season
One appointment, one injection, lasting peace of mind. £240, all-inclusive, at our Hampstead clinic.
Visit us
Hampstead Heath Pharmacy
35 South End Road, Hampstead, London NW3 2PY
Opening hours
Monday–Friday 09:00–18:30 · Saturday 09:00–17:30 · Sunday & bank holidays closed
General enquiries: 020 7435 7075 · info@hhpharmacy.co.uk
Appointments are booked online; we can't take bookings by phone.
Medically reviewed
Reviewed by Mahyar Saremi, Superintendent Pharmacist & Independent Prescriber (GPhC 2069409).
Last reviewed: 17 September 2026 (NHS eligibility expansion of 1 September 2026) · Next review due: September 2027, or sooner if NHS eligibility changes.
Regulated by the General Pharmaceutical Council · Premises No. 1040582. Hampstead Heath Pharmacy, registered in England & Wales (Company No. 01582798).
Abrysvo is a prescription-only medicine. This page provides information about a private vaccination service and is not a substitute for individual medical advice; your suitability will be assessed by our pharmacist. Always read the Patient Information Leaflet (or the SmPC). If you experience a side effect, you can report it through the Yellow Card scheme at yellowcard.mhra.gov.uk. This is a private service and is not provided under the NHS.